Search in:

Advanced search

Emerging Microbes & Infections Volume 5, 2016 - Issue 1

Submit an article Journal homepage

Open access

693

Views

CrossRef citations to date

Altmetric

Original Articles

Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice

Zoltán PaliczDepartment of Physiology, Faculty of Medicine, University of Debrecen, DebrecenH-4012, Hungary

Tamás GállDepartment of Physiology, Faculty of Medicine, University of Debrecen, DebrecenH-4012, Hungary

Éva LeiterDepartment of Biotechnology and Microbiology, Faculty of Science and Technology, University of Debrecen, DebrecenH-4032, Hungary

Sándor KollárDepartment of Pathology, Kenézy Gyula Hospital, DebrecenH-4031, Hungary

Ilona KovácsDepartment of Pathology, Kenézy Gyula Hospital, DebrecenH-4031, Hungary

Kornél Miszti-BlasiusDepartment of Laboratory Medicine, Medical Faculty, University of Debrecen, DebrecenH-4012, Hungary

István PócsiDepartment of Biotechnology and Microbiology, Faculty of Science and Technology, University of Debrecen, DebrecenH-4032, Hungary

László CsernochDepartment of Physiology, Faculty of Medicine, University of Debrecen, DebrecenH-4012, Hungary

Péter SzentesiDepartment of Physiology, Faculty of Medicine, University of Debrecen, DebrecenH-4012, HungaryCorrespondence[email protected]

show all

Pages 1-9 | Received 22 Apr 2016, Accepted 05 Sep 2016, Published online: 25 Jan 2019

Cite this article
https://doi.org/10.1038/emi.2016.116
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

MiceliMH,DíazJA,LeeSA.Emerging opportunistic yeast infections.Lancet Infect Dis2011; 11:142–151.
PubMed Web of Science ®Google Scholar
PfallerMA.Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.Am J Med2012; 125:S3–S13.
PubMed Web of Science ®Google Scholar
AbadA,Fernández-MolinaJV,BikandiJet al.What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis.Rev Iberoam Micol2010; 27:155–182.
PubMed Web of Science ®Google Scholar
KnutsenAP,SlavinRG.Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis.Clin Dev Immunol2011; 2011:843763.
PubMedGoogle Scholar
KoushaM,TadiR,SoubaniAO.Pulmonary aspergillosis: a clinical review.Eur Respir Rev2011; 20:156–174.
PubMedGoogle Scholar
MaertensJ,RaadI,PetrikkosGet al.Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.Clin Infect Dis2004; 39:1563–1571.
PubMed Web of Science ®Google Scholar
WalshTJ,AnaissieEJ,DenningDWet al.Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America.Clin Infect Dis2008; 46:327–360.
PubMed Web of Science ®Google Scholar
BassettiM,PecoriD,Della SiegaPet al.Current and future therapies for invasive aspergillosis.Pulm Pharmacol Ther2015; 32:155–165.
PubMed Web of Science ®Google Scholar
VandeputteP,FerrariS,CosteAT.Antifungal resistance and new strategies to control fungal infections.Int J Microbiol2012; 2012:713687.
PubMedGoogle Scholar
HowardSJ,CerarD,AndersonMJet al.Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure.Emerg Infect Dis2009; 15:1068–1076.
PubMed Web of Science ®Google Scholar
SuttonDA,SancheSE,RevankarSGet al.In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.J Clin Microbiol1999; 37:2343–2345.
PubMed Web of Science ®Google Scholar
MarxF,BinderU,LeiterEet al.The Penicillium chrysogenum antifungal protein PAF, a promising tool for the development of new antifungal therapies and fungal cell biology studies.Cell Mol Life Sci2008; 65:445–454.
PubMed Web of Science ®Google Scholar
HegedűsN,MarxF.Antifungal proteins: more than antimicrobials?Fungal Biol Rev2013; 26:132–145.
PubMed Web of Science ®Google Scholar
HegedűsN,SiglC,ZadraIet al.The paf gene product modulates asexual development in Penicillium chrysogenum.J Basic Microbiol2011; 51:253–262.
PubMed Web of Science ®Google Scholar
BattaG,BarnaT,GáspáriZet al.Functional aspects of the solution structure and dynamics of PAF—a highly-stable antifungal protein from Penicillium chrysogenum.FEBS J2009; 276:2875–2890.
PubMed Web of Science ®Google Scholar
KaisererL,OberparleiterC,Weiler-GorzRet al.Characterization of the Penicillium chrysogenum antifungal protein PAF.Arch Microbiol2003; 180:204–210.
PubMed Web of Science ®Google Scholar
GalgóczyL,PappT,PocsiIet al.In vitro activity of Penicillium chrysogenum antifungal protein (PAF) and its combination with fluconazole against different dermatophytes.Antonie Van Leeuwenhoek2008; 94:463–470.
PubMed Web of Science ®Google Scholar
OberparleiterC,KaisererL,HaasHet al.Active internalization of the Penicillium chrysogenum antifungal protein PAF in sensitive aspergilli.Antimicrob Agents Chemother2003; 47:3598–3601.
PubMed Web of Science ®Google Scholar
LeiterE,SzappanosH,OberparleiterCet al.Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype.Antimicrob Agents Chemother2005; 49:2445–2453.
PubMed Web of Science ®Google Scholar
HegedűsN,LeiterÉ,KovácsBet al.The small molecular mass antifungal protein of Penicillium chrysogenum—a mechanism of action oriented review.J Basic Microbiol2011; 51:561–571.
PubMed Web of Science ®Google Scholar
SzappanosH,SzigetiGP,PálBet al.The Penicillium chrysogenum-derived antifungal peptide shows no toxic effects on mammalian cells in the intended therapeutic concentration.Naunyn-Schmied Arch Pharmacol2005; 371:122–132.
PubMed Web of Science ®Google Scholar
PaliczZ,JenesA,GállTet al.In vivo application of a small molecular weight antifungal protein of Penicillium chrysogenum (PAF).Toxic Appl Pharmac2013; 269:8–16.
PubMed Web of Science ®Google Scholar
MarxF,HaasH,ReindlMet al.Cloning, structural organization and regulation of expression of the Penicillium chrysogenumpaf gene encoding an abundantly secreted protein with antifungal activity.Gene1995; 167:167–171.
PubMed Web of Science ®Google Scholar
Clinical and Laboratory Standards Institute.Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard,Document M38-A.Wayne, PA, USA: CLSI.2008.Available athttp://shop.clsi.org/site/Sample_pdf/M38A2_sample.pdf.
Google Scholar
OddsFC.Synergy, antagonism, and what the chequerboard puts between them.J Antimicrob Chemother2003; 52:1.
PubMed Web of Science ®Google Scholar
BarrattRW,JohnsonGB,OgataWN.Wild-type and mutant stocks of Aspergillus nidulans.Genetics1965; 52:233–246.
PubMed Web of Science ®Google Scholar
WarnPA,SharpA,MorrisseyGet al.Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.Int J Antimicrob Agents2010; 35:146–151.
PubMed Web of Science ®Google Scholar
WilsonDL.A comparison of methods for estimating mortality parameters from survival data.Mech Ageing Develop1993; 66:269–281.
PubMed Web of Science ®Google Scholar
KoulentiD,Garnacho-MonteromJ,BlotS.Approach to invasive pulmonary aspergillosis in critically ill patients.Curr Opin Infect Dis2014; 27:174–183.
PubMed Web of Science ®Google Scholar
MoenMD,Lyseng-WilliamsonKA,ScottLJ.Liposomal amphotericin B. A review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.Drugs2009; 69:361–392.
PubMed Web of Science ®Google Scholar
NajvarLK,CacciapuotiA,HernandezSet al.Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: Comparative studies in two laboratories.Antimicrob Agents Chemother2004; 48:758–764.
PubMed Web of Science ®Google Scholar
SpreghiniE,OrlandoF,SantinelliAet al.Anidulafungin in combination with Amphotericin B against Aspergillus fumigatus.Antimicrob Agents Chemother2009; 53:4035–4039.
PubMed Web of Science ®Google Scholar
ChangT,OlsonJA,ProffittRTet al.Differences in tissue drug concentrations following intravenous versus intraperitoneal treatment with amphotericin B deoxycholate or liposomal amphotericin B.Med Mycol2010; 48:430–435.
PubMed Web of Science ®Google Scholar
OlsonJA,SchwartzJA,HahkaDet al.Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.Med Mycol2015; 53:107–118.
PubMed Web of Science ®Google Scholar
ChryssanthouE.In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.Scand J Infect Dis1997; 29:509–512.
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date